The first study to compare the effectiveness of the birth control pill in women with marked weight differences has found that the pill works equally well in women with obesity and thinner women. This new finding by physician-scientists at NewYork-Presbyterian Hospital/Columbia University Medical Center refutes a long-held conviction among many doctors that the pill may not reliably prevent pregnancy in women who are overweight or obese.

One of the challenges of prostate cancer surgery is removing the cancer-affected gland without side effects. The procedure is estimated to cause long-term sexual dysfunction in half of men.

The day will come when people will be screened for hundreds of diseases through a simple blood test if the vision of the newest faculty recruit under the Strategic Plan for Research at Weill Cornell Medical College is fulfilled. Through new technology in "proteomics," which Dr. Samie R. Jaffrey is developing, conditions like pancreatic cancer will be diagnosed at a stage early enough so that there will be a good chance they can be treated and cured.

Dr. Zhong Sheng Sun, an Assistant Professor of Biochemistry in Pediatrics at Weill Cornell Medical College, has won a prestigious Mallinckrodt Foundation research award for his groundbreaking work in how biological clock genes affect the body’s circadian rhythms and how such genes function in the blood, in the immune system, and in metabolism.

In an unprecedented expansion of the international presence of American higher education, Cornell University and a private foundation organized by the Emir of Qatar announced today the establishment of the Weill Cornell Medical College in Qatar. The new medical college will offer a complete medical education in Qatar leading to a Cornell University M.D. degree, based on the same admission standards and curriculum as the New York campus.

Dr. Antonio M. Gotto, Jr., the Stephen and Suzanne Weiss Dean of Weill Medical College of Cornell University and a world-renowned authority in the field of cardiovascular medicine, has been elected a Fellow of the American Academy of Arts and Sciences.

Monitoring rejection in heart transplantation patients with a simple blood test co-developed by NewYork-Presbyterian Hospital/Columbia University Medical Center physician-scientist Dr. Mario Deng in 2005 can safely reduce their need for invasive heart-muscle biopsies, a new study has found.

An elevated resting heart rate that develops or persists during follow-up is associated with a significantly increased risk of death, whether from heart disease or other causes, researchers from the Ronald O. Perelman Heart Institute at NewYork-Presbyterian Hospital/Weill Cornell Medical Center found studying outcomes in more than 9,000 patients.